What SANKI does

SANKI Corporation is a Japanese pharmaceutical and medical product distributor headquartered in Hiroshima, operating as a wholly-owned subsidiary of Suzuken Group since 2003. Founded in 1965 as Koyo Yakuhin Co., Ltd. and renamed following a 1987 merger, the company serves approximately 8,000 medical institutions including hospitals, clinics, pharmacies, and nursing care facilities across the Chugoku region's five prefectures (Hiroshima, Okayama, Yamaguchi, Tottori, Shimane) through 17 branches and a route sales network that delivers to over 6,000 facilities daily. FY2026 revenue was 119.3 billion JPY with 856 employees and average tenure of 15.8 years. The group structure includes logistics (Sanki Medihart), home-visit care (Sanki Wellbe, 111 bases and 132 offices), and insurance pharmacy (Esmile) subsidiaries, providing vertical integration across the pharmaceutical-care-logistics value chain.

The company's core business is pharmaceutical distribution of approximately 18,000 products and medical device and material distribution of over 17,000 product lines. Its technology stack includes GDP-compliant logistics with dock shelters at dual logistics centers in Hiroshima and Okayama providing Business Continuity Planning, proprietary IoT-enabled VIXELL temperature-controlled transport boxes with 72-hour cold chain capability for biologics and specialty drugs, and the Cubicx RFID-enabled refrigerated storage system with non-contact power supply. The medical DX / digital services vertical includes the medimo AI-powered voice-to-medical-record service, Collabo Portal, MCS multi-disciplinary communication tool, IoT smart mat inventory management, an order proposal app using 2 years of historical delivery pattern analysis, and integrations with third-party platforms including Welby patient self-management and Ubie AI consultation.

SANKI's revenue model centers on transaction-fee pharmaceutical and medical product sales, supplemented by recurring digital service subscriptions (medimo, Welby, MCS), hardware rentals (VIXELL boxes, medical devices), and professional services for new clinic establishment support including consulting, site selection, financing, and regulatory compliance. GTM is exclusively direct field sales via Medical Sales (MS) representatives. The company is geographically constrained to the Chugoku region, with broader Japan-wide reach handled by parent Suzuken Group. Recent strategic emphasis has been placed on ISO9001 quality certification, community health partnerships (Miyoshi City), and digital service layer expansion rather than geographic expansion outside its existing footprint.

Name

SANKI

Legal name

株式会社サンキ（SANKI CORPORATION）

Website

https://kksanki.co.jp

Company type

Private

Founded year

1965

Operating status

Operating

Headcount range

501–1,000 employees

Short description

SANKI is a wholly-owned Suzuken Group subsidiary distributing approximately 18,000 pharmaceuticals and 17,000+ medical products to about 8,000 hospitals, clinics, and pharmacies across the Chugoku region of Japan via 17 branches and daily route sales, supplemented by medical DX services and clinic establishment support.

Ownership category

akta.pro rank

Headquarters

HQ city

Hiroshima

HQ country

Japan

HQ region

Asia

Offices15 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical distribution: Sale of approximately 18,000 pharmaceutical products to medical institutions and pharmacies with daily delivery route operations
2. Medical device and material sales: Sale of medical equipment, diagnostic reagents, medical materials, and healthcare products. Over 17,000 product lines beyond pharmaceuticals.
3. Digital service provision: Provision of digital solutions including AI medical record services, DX platforms, and communication tools to healthcare facilities
4. Clinic start-up support services: Professional services supporting new medical facility establishment including consulting, facility planning, and regulatory compliance
5. Rental services: Medical equipment and device rental including VIXELL temperature-controlled boxes and medical devices

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

SANKI is a pharmaceutical and medical product wholesale distributor operating in the Chugoku region of Japan. The company distributes approximately 18,000 pharmaceutical products and over 17,000 medical products to more than 8,000 medical institutions, delivering daily to over 6,000 facilities through a route sales network. It also offers cold-chain logistics solutions, digital healthcare services, and consulting support for physicians establishing new clinics.

Product overview

SANKI operates as a pharmaceutical and medical product distributor within the Suzuken Group, organized around four core business areas: pharmaceutical distribution (approximately 18,000 pharmaceutical products serving 8,000+ medical institutions), medical product distribution (over 17,000 medical supplies and devices), medical DX and digital services, and new clinic opening support. The product portfolio centers on pharmaceutical distribution with medical equipment and supplies as the primary offering, supplemented by a digital services layer (either proprietary or through technology partnerships) including AI-powered medical record creation (medimo), cold chain management systems (VIXELL, Cubix), hospital communication tools (MCS), and third-party health platforms (Welby, Ubie AI consultation). The digital services function as enablers that enhance the core pharmaceutical distribution business rather than standalone products.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Distribution Service
• Medical Device and Material Distribution
• VIXELL Temperature-Controlled Transport Box Rental
• Cubicx Cold Chain System
• medimo AI Medical Record Service
• Collabo Portal
• Medical Care Station (MCS)
• SPD Hospital Efficiency Support
• Order Proposal App
• Delivery Schedule App and Notification Service
• Clinic Establishment Support Service
• Welby My Karte Patient Health App
• Welby My Karte ONC Cancer Patient App
• Ubie AI Patient Consultation Service
• Smart Mart IoT Inventory Management Solution
• Holter ECG Analysis Service
• Specialty Pharmaceutical Distribution (Anticancer and Biologics)

Quantifiable outcome

• Daily deliveries to over 6,000 medical facilities across Chugoku region
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability4 records

Feature4 records

Partnerships

Six partnerships are on record, tiered regional, core and supporting.

• 三次市 (Miyoshi City)regionalStrategic or Co-development Partner · 11 March 2026Partnership agreement for community health promotion including health building initiatives, vaccination programs, cancer countermeasures, and SDG-related activities. Focuses on improving citizen services and regional revitalization.
• ヘルステック企業 (Health tech companies)coreTechnology or IntegrationPartnership with health technology companies to provide digital solutions platform connecting patients, healthcare providers, pharmaceutical companies, and local governments. Enables AI medical record services, telemedicine solutions, and DX integration for healthcare facilities.
• 株式会社日本アルトマーク (Japan Altmark Co., Ltd.)supportingStrategic or Co-development PartnerCo-use of Altmark's Medical Database (MDB) with other pharmaceutical companies, medical device manufacturers, and healthcare companies in the industry. Shared use of nationwide medical institution information including facility names, addresses, and representative details for targeted service provision.
• サンキ・ウエルビィ株式会社 (Sanki Wellbe Co., Ltd.)coreStrategic or Co-development PartnerGroup subsidiary providing home care services including 111 bases and 132 offices in the Chugoku region. Offers wide range of care services from support for those requiring nursing care to residential services. Also advancing productivity improvement through introduction of nursing care robots and fall prevention sensors.
• 株式会社エスマイル (Smile Co., Ltd.)coreStrategic or Co-development PartnerInsurance pharmacy chain operating in the Chugoku area. Provides patient-centered services through multi-disciplinary collaboration with doctors, nurses, and care workers. Contributes to community health through team orange activities, health consultation events, and nutrition/diet consultation events.
• 有限会社サンキ・メディハート (Sanki Medihart Co., Ltd.)coreStrategic or Co-development PartnerGroup logistics company handling pharmaceutical and medical material distribution for SANKI Group. Maintains strict quality control to ensure reliable and rapid delivery of temperature-sensitive medical products to healthcare facilities, clinics, pharmacies, and nursing care facilities.

Scale indicators9 records

Recent moves9 records

Expansion highlights4 records

Emerging players

• Welby, Inc. Japanese digital health company providing patient-facing self-management apps (Welby MyKarte, Welby MyKarte ONC) that SANKI distributes and integrates into its digital services portfolio. Comparable as a partner-level peer in the medical DX layer that SANKI offers alongside its core pharmaceutical distribution.
• M3, Inc. Japanese healthcare technology platform operating medical DX services (MR-kun, clinical decision support, platform services for physicians). Comparable to SANKI's medical-DX digital services layer, particularly medimo and the Collabo Portal, though M3's core focus is on pharma-marketing platforms and physician-facing SaaS rather than wholesale distribution.

Direct peers

• Alfresa Holdings Corporation: Member of Japan's Big Four pharmaceutical wholesalers with national coverage, including pharmaceutical distribution, medical equipment, and healthcare services. Closely comparable business model to SANKI, with broader geographic reach and additional segments such as self-medication and pharmaceutical manufacturing.
• Mediceo Corporation: Pharmaceutical wholesaling subsidiary of Medipal Holdings, providing national pharma distribution and medical supply services. Closely comparable to SANKI in core distribution operations, customer base, and route-sales service model.
• Medipal Holdings Corporation: Japan's largest pharmaceutical wholesaler, operating a national distribution network through subsidiaries such as Mediceo. Directly comparable to SANKI in product portfolio (pharmaceuticals and medical devices), customer base (hospitals, clinics, pharmacies), and route-sales model — but at materially larger, national scale.
• Toho Holdings Co., Ltd. National pharmaceutical wholesaler with subsidiaries across Japan, distributing pharmaceuticals, medical devices, and providing healthcare DX services. Directly comparable to SANKI's product mix, route-sales approach, and digital-service layering on top of distribution.
• Sogo Medical Service Co., Ltd. Regional pharmaceutical wholesaler headquartered in Fukuoka, distributing pharmaceuticals and medical devices to hospitals, clinics, and pharmacies, primarily in Kyushu. Comparable to SANKI as a regional pharma wholesaler with similar route-sales and customer-engagement model, though operating in a different geography.
• Nihon Pharmaceutical Co., Ltd. Pharmaceutical wholesaler distributing to medical institutions and pharmacies across Japan. Comparable to SANKI in product mix, customer segments, and the daily-delivery distribution model that anchors the regional wholesaler value proposition.

Broad incumbents

• Suzuken Co., Ltd. 100% parent company of SANKI and one of Japan's Big Four pharmaceutical wholesalers with national/international distribution and group-wide digital products (medimo, MCS, VIXELL). Comparable as the parent platform underlying SANKI's product portfolio and source of group-wide procurement leverage.
• PHC Holdings Corporation: Healthcare company spanning medical devices, diagnostics, and life sciences. Overlaps with SANKI in the medical-device and diagnostic-reagent distribution portion of its portfolio, and is a comparable supplier/category player in the broader healthcare supply chain in Japan.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks1 record

Key highlights7 records

Customer concentration

• Instagraminstagram.com/sanki__since1965

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SANKI